188 related articles for article (PubMed ID: 36709279)
1. A prognostic model based on necroptosis-related genes for prognosis and therapy in bladder cancer.
Wang Z; Huang Z; Cao X; Zhang F; Cai J; Tang P; Yang C; Li S; Yu D; Yan Y; Shen B
BMC Urol; 2023 Jan; 23(1):10. PubMed ID: 36709279
[TBL] [Abstract][Full Text] [Related]
2. MLKL and other necroptosis-related genes promote the tumor immune cell infiltration, guiding for the administration of immunotherapy in bladder urothelial carcinoma.
Zhong B; Wang Y; Liao Y; Liang J; Wang K; Zhou D; Zhao Y; Jiang N
Apoptosis; 2023 Jun; 28(5-6):892-911. PubMed ID: 37000317
[TBL] [Abstract][Full Text] [Related]
3. Predicting Prognosis and Distinguishing Cold and Hot Tumors in Bladder Urothelial Carcinoma Based on Necroptosis-Associated lncRNAs.
Liu D; Xu S; Chang T; Ma S; Wang K; Sun G; Chen S; Xu Y; Zhang H
Front Immunol; 2022; 13():916800. PubMed ID: 35860239
[TBL] [Abstract][Full Text] [Related]
4. Identification of molecular subtypes, risk signature, and immune landscape mediated by necroptosis-related genes in non-small cell lung cancer.
Zhu J; Wang J; Wang T; Zhou H; Xu M; Zha J; Feng C; Shen Z; Jiang Y; Chen J
Front Oncol; 2022; 12():955186. PubMed ID: 35965497
[TBL] [Abstract][Full Text] [Related]
5. Prognosis Risk Model Based on Necroptosis-Related Signature for Bladder Cancer.
Chen Z; Cao R; Wang R; Wang Y; Shang D; Tian Y
Genes (Basel); 2022 Nov; 13(11):. PubMed ID: 36421795
[TBL] [Abstract][Full Text] [Related]
6. Identification and Quantification of Necroptosis Landscape on Therapy and Prognosis in Kidney Renal Clear Cell Carcinoma.
Xin S; Mao J; Duan C; Wang J; Lu Y; Yang J; Hu J; Liu X; Guan W; Wang T; Wang S; Liu J; Song W; Song X
Front Genet; 2022; 13():832046. PubMed ID: 35237304
[TBL] [Abstract][Full Text] [Related]
7. A novel model based on necroptosis-related genes for predicting immune status and prognosis in glioma.
Yuan YS; Jin X; Chen L; Liao JM; Zhang Y; Yu KW; Li WK; Cao SW; Huang XZ; Kang CM
Front Immunol; 2022; 13():1027794. PubMed ID: 36389690
[TBL] [Abstract][Full Text] [Related]
8. Analysis and identification of the necroptosis landscape on therapy and prognosis in bladder cancer.
Zhao Z; Jiang N; Zhang Y; Bai Y; Liu T; Li T; Guo H; Yang R
Front Genet; 2022; 13():919829. PubMed ID: 36246597
[TBL] [Abstract][Full Text] [Related]
9. A novel necroptosis-related gene index for predicting prognosis and a cold tumor immune microenvironment in stomach adenocarcinoma.
Khan M; Lin J; Wang B; Chen C; Huang Z; Tian Y; Yuan Y; Bu J
Front Immunol; 2022; 13():968165. PubMed ID: 36389725
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of a necroptosis-related gene prognostic score to predict prognosis and efficiency of immunotherapy in gastric cancer.
Xia Y; Zhang R; Wang M; Li J; Dong J; He K; Guo T; Ju X; Ru J; Zhang S; Sun Y
Front Immunol; 2022; 13():977338. PubMed ID: 36159818
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive analysis of anoikis-related long non-coding RNA immune infiltration in patients with bladder cancer and immunotherapy.
Zhang YY; Li XW; Li XD; Zhou TT; Chen C; Liu JW; Wang L; Jiang X; Wang L; Liu M; Zhao YG; Li SD
Front Immunol; 2022; 13():1055304. PubMed ID: 36505486
[TBL] [Abstract][Full Text] [Related]
12. Construction and validation of a bladder cancer risk model based on autophagy-related genes.
Shen C; Yan Y; Yang S; Wang Z; Wu Z; Li Z; Zhang Z; Lin Y; Li P; Hu H
Funct Integr Genomics; 2023 Jan; 23(1):46. PubMed ID: 36689018
[TBL] [Abstract][Full Text] [Related]
13. A multi-omics-based investigation of the prognostic and immunological impact of necroptosis-related mRNA in patients with cervical squamous carcinoma and adenocarcinoma.
Zou J; Lin Z; Jiao W; Chen J; Lin L; Zhang F; Zhang X; Zhao J
Sci Rep; 2022 Oct; 12(1):16773. PubMed ID: 36202899
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive Characterization of Necroptosis-Related lncRNAs in Bladder Cancer Identifies a Novel Signature for Prognosis Prediction.
XiaYu K; GuoGang C; CanXuan L; WeiBin X
Dis Markers; 2022; 2022():2360299. PubMed ID: 35711565
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological and Prognostic Value of Necroptosis-Associated lncRNA Model in Patients with Kidney Renal Clear Cell Carcinoma.
Gu J; He Z; Huang Y; Luan T; Chen Z; Wang J; Ding M
Dis Markers; 2022; 2022():5204831. PubMed ID: 35664432
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive
Xu T; Xu W; Zheng Y; Li X; Cai H; Xu Z; Zou Q; Yu B
Front Immunol; 2022; 13():931906. PubMed ID: 35958598
[TBL] [Abstract][Full Text] [Related]
17. Cuproptosis scoring system to predict the clinical outcome and immune response in bladder cancer.
Song Q; Zhou R; Shu F; Fu W
Front Immunol; 2022; 13():958368. PubMed ID: 35990642
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive Profiling Reveals Prognostic and Immunogenic Characteristics of Necroptosis in Soft Tissue Sarcomas.
Qi L; Xu R; Ren X; Zhang W; Yang Z; Tu C; Li Z
Front Immunol; 2022; 13():877815. PubMed ID: 35663937
[TBL] [Abstract][Full Text] [Related]
19. Identification and Verification of Necroptosis-Related Gene Signature With Prognosis and Tumor Immune Microenvironment in Ovarian Cancer.
Wang Z; Chen G; Dai F; Liu S; Hu W; Cheng Y
Front Immunol; 2022; 13():894718. PubMed ID: 35812403
[TBL] [Abstract][Full Text] [Related]
20. Construction and validation of a necroptosis-related lncRNAs prognosis signature of hepatocellular carcinoma.
Peng Y; Wu G; Qiu X; Luo Y; Zou Y; Wei X; Li A
Front Genet; 2022; 13():916024. PubMed ID: 36110223
[No Abstract] [Full Text] [Related]
[Next] [New Search]
